EichorEICHOR
Location: Trieste Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Trieste

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL
Phase N/A · IRCCS materno infantile Burlo Garofolo · IRCCS Burlo Garofolo · NCT05811845Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Istituto Di Ricovero E Cura A Carattere Scientifico Materno · Princess Maxima Center for Pediatric Oncology · NCT05327894Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Phase 3 · Azienda Sanitaria Universitaria Integrata Di Trieste - Sc Em · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04168502A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · IRCCS Materno Infantile Burlo Garofolo · Alfasigma S.p.A. · NCT06865417Observational Study on Skeletal Ewing's Sarcoma
Phase N/A · IRCCS materno infantile Burlo Garofolo · Italian Sarcoma Group · NCT04845893A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pou
Phase 3 · IRCCS Materno Infantile Burlo Garofolo · Takeda · NCT06443502Subendocardial Viability Ratio in Hypertension
Phase N/A · Dipartimento di Scienze Mediche, Chirurgiche e della Salute, · Istituto Auxologico Italiano · NCT06309511Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · OSPEDALE MAGGIORE ASUGI - UCO Ematologia · The Lymphoma Academic Research Organisation · NCT06006117A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Osp. di Cattinara · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Azienda Sanitaria Universitaria Integrata · argenx · NCT06544499Study on the Diagnosis and Management of CLL in Italy by GIMEMA
Phase N/A · UCO Ematologia ASUGI Trieste · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04867915Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NA · Ospedale Burlo Garofolo · Meyer Children's Hospital IRCCS · NCT06921993Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · ASUGI Ospedale Maggiore di Trieste · Kura Oncology, Inc. · NCT07007312Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Phase 3 · Trieste - Azienda Sanitaria Universitaria Giuliano Isontina · Fondazione Italiana Linfomi - ETS · NCT04442412Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies
NA · Azienda Sanitaria Universitaria Giuliano Isontina · Azienda Ospedaliero-Universitaria di Modena · NCT06855901Multicentre Prospective Observational Study of Acute Intoxications in Paediatric Age
Phase N/A · Burlo Garofalo · Meyer Children's Hospital IRCCS · NCT06291649High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Phase 3 · IRCCS Burlo Garoflo oncoematologia · Gustave Roussy, Cancer Campus, Grand Paris · NCT04221035Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiov
Phase N/A · Azienda sanitaria universitaria Giuliano Isontina (ASUGI) · Centro Cardiologico Monzino · NCT06884631Epidemiological Study on Invasive Bacterial Diseases
Phase N/A · IRCCS Materno Infantile Burlo Garofolo · Meyer Children's Hospital IRCCS · NCT06322290Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity.
Phase N/A · Department of Medical, Surgical and Health Sciences, Univers · University of Roma La Sapienza · NCT06545435Focusing the Shoulder or Considering the Whole-Body in Volleyball Physiotherapy
NA · University of Trieste - Exercise Physiology and Kinesiology · University of Trieste · NCT07072091A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Ly
Phase N/A · Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - · Fondazione Italiana Linfomi - ETS · NCT06008691A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Phase 3 · IRCCS Materno Infantile Burlo Garofolo · Janssen Research & Development, LLC · NCT06663332A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Phase 3 · Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - · argenx · NCT07091630Ultrasonography in Children With First Febrile Urinary Tract Infection
Phase N/A · IRCCS materno infantile Burlo Garofolo · IRCCS Burlo Garofolo · NCT05814250A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Phase 3 · Giuliano Isontina University Health Authority · Basilea Pharmaceutica · NCT06925321International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Istituto Di Ricovero E Cura A Carattere Scientifico Materno · University Hospital Muenster · NCT04043494Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Ly
Phase N/A · A.S.U. Giuliano Isontina - S.C. Ematologia · Fondazione Italiana Linfomi - ETS · NCT06588205A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Azienda Sanitaria Universitaria Integrata di Trieste · Nordic Lymphoma Group · NCT04332822A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection
NA · Az. San. Univ. Giuliano Isontina (ASU GI) · Umbria Bioengineering Technologies · NCT05300464
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.